Skip to main content

Table 2 Surviving fraction (SF) at tested radiation and bleomycin doses

From: Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells

Radiation (Gy)

SF TTFields + RT

SFTTFields × SFRT

Radiosensitization effect

U-118 MG

 2

0.292

0.363

Synergism

 4

0.169

0.273

Synergism

 6

0.061

0.154

Synergism

 8

0.021

0.107

Synergism

LN-18

Radiation (Gy)

SF TTFields + RT

SFTTFields × SFRT

Radiosensitization effect

 2

0.025

0.054

Synergism

 4

0.005

0.013

Synergism

 6

0.001

0.004

Synergism

 8

0.000

0.001

Synergism

U-118 MG

Bleomycin [μg/ml]

SF TTFields + Bleomycin

SFTTFields × SFBleomycin

Chemosensitization effect

 0.4

0.433

0.591

Synergism

 1.5

0.500

0.606

Synergism

 6.25

0.410

0.555

Synergism

 25

0.255

0.411

Synergism

 100

0.105

0.277

Synergism